Scripps Front Row Lecture Series: Mapping the Secret Complexity of Tumors to Defeat Aggressive Cancer
About the Event
Michalina Janiszewska, PhD, Assistant Professor, Department of Molecular Medicine, Scripps Research
Mapping the secret complexity of tumors to defeat aggressive cancer
Why do so many cancer patients respond well to a particular treatment, only to relapse months or years later? The answer lies within the complex cellular makeup of cancerous tumors. Since cells within a tumor vary widely from one another, even if most are destroyed, at least some will survive and rebuild the tumor mass.
Cancer biologist Michalina Janiszewska, PhD, assistant professor in the Department of Molecular Medicine at Scripps Research, brings a heightened understanding to how a tumor’s diverse cell populations interact and what causes cells with particular mutations to expand. Likening tumors to jigsaw puzzles, Janiszewska is finding patterns that were never before seen. By mapping the intricate tumor ecosystem and finding new ways to detect the most dangerous of cells, she seeks to bring about better treatments for brain cancer and other highly aggressive or treatment-resistant tumors.
WHO: Scripps Research invites the public to join a free virtual series of live science lectures, called Front Row.
WHAT: Scripps Research scientists share their discoveries and successes as they work to solve the most pressing challenges of modern human health. Researchers at the forefront of their fields share data and interactively answer questions about COVID-19, cancer, vision loss, chronic inflammation and more. Sign up for a seat in the Front Row and enjoy compelling presentations, and an insider’s look at what’s next in biomedical research.
WHERE: The series takes place entirely online, so guests can join from the comfort of their own homes, either over the phone or on the computer. Advance registration is required. For more information, email firstname.lastname@example.org.
WHEN: Each one-hour lecture begins at 1 p.m. PT, 4:00 p.m. ET.
WHY: What makes cancer so difficult to defeat? Why does the immune system sometimes misfire and attack healthy tissue? How does the eye turn light into information? Answering these questions helps scientists develop urgently needed new treatments for conditions awaiting better options. One of America’s great innovators, Scripps Research President and CEO Peter Schultz, PhD, kicks off the series with a talk on how the nonprofit biomedical institute has expanded the bounds of academic research to transform and accelerate drug development efforts, to address unmet medical needs around the world.
To watch past Front Row lectures, subscribe to the Scripps Research YouTube channel.